September 23, 2013

CAS databases provide millions of journal article references from more than 10,000 major scientific journals worldwide, patent and patent family references from 63 patent authorities around the world, and other reputable web sources.

The following patent record is from the CAplusSM database.

CAPLUS COPYRIGHT 2013 ACS

Patent Number: WO 2013096093
Title: Preparation of triazolylpyridine derivatives and analogs for use as DGAT-1 inhibitors
Inventor(s): Devita, Robert J.; He, Shuwen; Liu, Jian; Cernak, Timothy A.; Krikorian, Arto D.; Yang, Ginger Xuqiang; Wu, Zhicai; Yu, Yang; Shen, Dong-Ming; Lai, Zhong; Hong, Qingmei; Nargund, Ravi P.
Patent Assignee(s): Merck Sharp & Dohme Corp., USA
Source: PCT Int. Appl., 119pp. CODEN: PIXXD2
Language: English

Abstract:
Title compds. I [T = bond or O; U = (un)substituted Ph, pyridinyl, pyrimidinyl, etc.; V and X independently = CH or N; Y and Z independently = N, CH, or CR2; R1 = alkoxy, (un)substituted pyridinyl, cyclohexanyl, etc.; R2 = (un)substituted alkyl, Ph, cycloalkyl, etc.; R3 = halo, CN, alkyl or alkoxy and is optionally present at one of more of the ring carbons; provided at least one X, Y, or Z is N], and their pharmaceutically acceptable salts, are prepd. and disclosed as DGAT-1 inhibitors.  Thus, e.g., II was prepd. by a multistep procedure (prepn. given).  Select I were evaluated in hDGAT1 assays (data given).

Please note:  Abstracts and Titles for patent records in CAplus are routinely enhanced to better describe the claimed invention.

 View the full-text here.

Recent News

 
    April 17, 2014 | Multi-Year Deal Secures SciFinder
    Access for Prague Consortium Researchers

    April 16, 2014 | New Format Adopted for Taiwanese
    Granted Patent Numbers in CAS Databases and
    INPADOC

    March 26, 2014 | New STN Platform Enhancements
    Available, Increase Efficiency of Search Workflow

                                                                       More News >> 

 Media Contact

 Name: Rhonda Ross
 Phone: 614-447-3624                                       
 Email: cas-pr@cas.org